Latest News and Press Releases

VYN201 0.1% and 1% resulted in statistically significant improvement in reducing both melanocyte loss and key inflammatory biomarkers involved in the pathogenesis of vitiligo, an immune-modulated skin...

VANCOUVER, British Columbia, March 07, 2022 (GLOBE NEWSWIRE) -- Aton Resources Inc. (AAN: TSX-V) (“Aton” or the “Company") is very pleased to update investors on the latest tranche of results from...

BRIDGEVILLE, Pa., March 07, 2022 (GLOBE NEWSWIRE) -- Universal Stainless & Alloy Products, Inc. (Nasdaq: USAP) today announced that it will be increasing the nickel premium used in its raw...

An Investigator Initiated Phase 2 Clinical Trial of TNX-1900 In Patients with Binge Eating Disorder Planned for Second Half 2022 Binge Eating Disorder is Estimated to Affect 2.8 Million American...

PALMETTO, Fla., March 07, 2022 (GLOBE NEWSWIRE) -- It Works! celebrated this past year its 20th anniversary as a global beauty and wellness company by highlighting the continued growth of Manatee...

NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company”), today announced that Jeffrey Meckler, Chief Executive Officer, will participate...

TORONTO, March 07, 2022 (GLOBE NEWSWIRE) -- JOURDAN RESOURCES INC. (TSXV: JOR; OTCQB: JORFF) (“Jourdan” or the “Company“) is pleased to announce that all of its first four drill holes of its winter...

DALLAS, March 07, 2022 (GLOBE NEWSWIRE) -- Builders FirstSource, Inc. (NYSE: BLDR) (“Builders FirstSource”), today announced that Amy Bass Messersmith will be joining Builders FirstSource as its...

WATERTOWN, Mass., March 07, 2022 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve...

The parties have entered into a collaboration agreement to develop Targovax´s TG mutant KRAS cancer vaccines in combination with Agenus´s QS-21 STIMULON adjuvant technologyThe agreement may be...